Distinct Mutation Patterns in Black Patients Challenge Current AML Risk Stratification

Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzRacial disparities in acute myeloid leukemia (AML) outcomes persist, with Black patients exhibiting distinct molecular biology resulting in diminished prognostic value for traditionally favorable mutations, researchers reported at the 2026 ASCO Annual Meeting, in Chicago (abstract 6534).figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }fig